MARKET

DGX

DGX

QuestDiagnostics
NYSE

Real-time Quotes | Nasdaq Last Sale

153.09
-0.43
-0.28%
After Hours: 152.56 -0.53 -0.35% 17:14 09/24 EDT
OPEN
153.53
PREV CLOSE
153.52
HIGH
154.31
LOW
152.37
VOLUME
658.60K
TURNOVER
--
52 WEEK HIGH
160.56
52 WEEK LOW
108.28
MARKET CAP
18.70B
P/E (TTM)
9.12
1D
5D
1M
3M
1Y
5Y
Black and Hispanic Communities Are Lagging in Getting Vaccinated. How These Organizations Are Trying to Change That
by Eric Berger
News Direct · 1d ago
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks · 3d ago
Bet on These 3 MedTech Growth Stocks for 2021 & Beyond
Stocks like West Pharmaceutical Services (WST), IDEXX Laboratories (IDXX) and Align Technology (ALGN) make great picks for the long term.
Zacks · 3d ago
3 Stocks to Buy if You're Worried About a Stock Market Crash
StockNews.com · 4d ago
Quest Diagnostics' (DGX) COVID-19 Test Demand Up in Q3 Months
Zacks.com · 5d ago
Quest Diagnostics Says Evaluating Opportunities To Scale Lab Testing Capacity And Rapid Antigen Test Inventory Should COVID-19 Test Demand Increase; Says Has Performed And Reported Over 55.5M Molecular Diagnostic And Antibody Serology Tests Since 2020
-Reuters
Reuters · 09/14 20:06
Quest Diagnostics Says Evaluating New Federal COVID-19 Action Plan, Potential Implications, Once Specific Requirements Are Included In Pending OSHA Rule
-Reuters
Reuters · 09/14 20:03
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate
Zacks.com · 09/14 13:58
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DGX. Analyze the recent business situations of QuestDiagnostics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DGX stock price target is 157.67 with a high estimate of 181.00 and a low estimate of 130.00.
EPS
Institutional Holdings
Institutions: 1.08K
Institutional Holdings: 128.67M
% Owned: 105.31%
Shares Outstanding: 122.18M
TypeInstitutionsShares
Increased
287
6.31M
New
60
1.97M
Decreased
278
7.53M
Sold Out
62
489.16K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.84%
Healthcare Providers & Services
-0.36%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen Rusckowski
Chief Financial Officer/Executive Vice President
Mark Guinan
Executive Vice President
James Davis
Senior Vice President/General Counsel
Michael Prevoznik
Senior Vice President
Catherine Doherty
Senior Vice President
Carrie Manner
Independent Director
Tracey Doi
Independent Director
Vicky Gregg
Independent Director
Wright Lassiter
Independent Director
Timothy Main
Independent Director
Denise Morrison
Independent Director
Gary Pfeiffer
Independent Director
Timothy Ring
Independent Director
Helen Torley
Independent Director
Gail Wilensky
Declaration Date
Dividend Per Share
Ex-Div Date
05/20/2021
Dividend USD 0.62
07/06/2021
02/04/2021
Dividend USD 0.62
04/06/2021
11/18/2020
Dividend USD 0.56
01/19/2021
08/18/2020
Dividend USD 0.56
10/05/2020
05/18/2020
Dividend USD 0.56
07/07/2020
01/30/2020
Dividend USD 0.56
04/06/2020
11/20/2019
Dividend USD 0.53
01/13/2020
08/15/2019
Dividend USD 0.53
10/03/2019
05/14/2019
Dividend USD 0.53
07/05/2019
03/01/2019
Dividend USD 0.53
04/05/2019
11/28/2018
Dividend USD 0.53
01/14/2019
08/17/2018
Dividend USD 0.5
10/04/2018
05/14/2018
Dividend USD 0.5
07/06/2018
02/01/2018
Dividend USD 0.5
04/03/2018
11/29/2017
Dividend USD 0.45
01/08/2018
08/18/2017
Dividend USD 0.45
10/02/2017
05/16/2017
Dividend USD 0.45
07/06/2017
02/21/2017
Dividend USD 0.45
04/03/2017
11/21/2016
Dividend USD 0.45
01/06/2017
08/17/2016
Dividend USD 0.4
09/30/2016
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, and other brands, such as AmeriPath, Dermpath Diagnostics, ExamOne, Quanum. It also helps in delivering diagnostic insights for COVID-19 and a range of other medical conditions for communities in South Florida.

Webull offers kinds of Quest Diagnostics Inc stock information, including NYSE:DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.